South Korea Clinical Trial Imaging Market Size & Outlook

The clinical trial imaging market in South Korea is expected to reach a projected revenue of US$ 47.8 million by 2030. A compound annual growth rate of 7.6% is expected of South Korea clinical trial imaging market from 2025 to 2030.
Revenue, 2024 (US$M)
$30.9
Forecast, 2030 (US$M)
$47.8
CAGR, 2025 - 2030
7.6%
Report Coverage
South Korea

South Korea clinical trial imaging market highlights

  • The South Korea clinical trial imaging market generated a revenue of USD 20.6 million in 2023 and is expected to reach USD 36.7 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 8.6% from 2024 to 2030.
  • In terms of segment, project and data management was the largest revenue generating service in 2023.
  • Clinical Trial Design and Consultation Services is the most lucrative service segment registering the fastest growth during the forecast period.


Clinical trial imaging market data book summary

Market revenue in 2023USD 20.6 million
Market revenue in 2030USD 36.7 million
Growth rate8.6% (CAGR from 2023 to 2030)
Largest segmentProject and data management
Fastest growing segmentClinical Trial Design and Consultation Services
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationClinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management
Key market players worldwideIxico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.8% of the global clinical trial imaging market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China clinical trial imaging market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 86.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Clinical Trial Imaging Market Scope

Clinical trial imaging market segmentation & scope
Countries
UK
UAE
Mexico
Sweden
Denmark
Norway
Australia
Kuwait

Clinical Trial Imaging Market Companies

Name Profile # Employees HQ Website

South Korea clinical trial imaging market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.


Project and data management was the largest segment with a revenue share of 28.64% in 2024. Horizon Databook has segmented the South Korea clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.


Clinical trial imaging market in South Korea is expected to exhibit gradual growth during the forecast period. South Korea has become one of the top Asian countries for conducting clinical trials owing to the presence of quality clinical research infrastructure. 

Moreover, the country has recently implemented various protection and safety requirements for clinical trial participants. Moreover, the government has partnered with large CROs to provide effective clinical trial services in the country. 

In September 2019, South Korea launched a five-year plan for advancing clinical trials in the country. One of the major advantages that is being offered under this plan is accelerated clinical trial study with reduced review timelines of around 15 to 20 days. 

Reasons to subscribe to South Korea clinical trial imaging market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea clinical trial imaging market databook

  • Our clientele includes a mix of clinical trial imaging market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea clinical trial imaging market , including forecasts for subscribers. This country databook contains high-level insights into South Korea clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea clinical trial imaging market size, by modality, 2018-2030 (US$M)

South Korea Clinical Trial Imaging Market Outlook Share, 2024 & 2030 (US$M)

South Korea clinical trial imaging market size, by modality, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more